Tempus | AI-enabled precision medicine
Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.
Tempus Announces National Launch of olivia, its AI-enabled …
2025年1月21日 · AI-enabled Notetaker: olivia can provide patients with written transcripts, audio files, and smart summaries of physician appointments, accessible and searchable via the …
Next - Tempus
Learn more about Tempus Next. Chris Scotto DiVetta, SVP of Applications at Tempus AI introduces Tempus Next, an AI enabled care pathway platform that helps providers accelerate …
Precision medicine made real: enhancing genetic testing with AI ...
2023年2月1日 · We’ve built a variety of these AI-driven algorithms at Tempus. Our Tempus|TO (or tumor origin) test uses RNA expression results from tumor metastases to predict the …
Investor Relations | Tempus AI
With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, …
Press Releases | News | Tempus
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the company’s …
Tempus Launches Beta Version of olivia, its AI-enabled Personal …
2024年9月12日 · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a …
Tempus Announces Preliminary Fourth Quarter and Full Year 2024 …
2025年1月13日 · CHICAGO--(BUSINESS WIRE)--Jan. 13, 2025-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and …
Tempus Completes Acquisition of Ambry Genetics
2025年2月3日 · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its …
Eric Lefkofsky - Tempus
Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and precision medicine. He is the co-founder and General Partner of Lightbank, a private venture capital firm …